Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1126 | 1127 | (Page 1128) | 1129 | 1130 | .... | 1146 | newer

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) The demand for vertebral radiculopathy market is increasing with the rise in the number of patients suffering from osteoporosis, slipped discs and osteoarthritis. According to a report from CDC (centre of Disease control and prevention), an estimated 54.4 million US adults (22.7%) in 2013- 2015 were suffering from arthritis. With growing need and increasing number of patient pools, the healthcare expenditure is increasing in nation wise to improve hospitals infrastructures along with development of new drugs. Moreover the growth of the market is expected due to the powerful regulations and patient safety. Also increasing investment and R&D will overcome the deficiencies for better alternatives for the Vertebral Radiculopathy Market Growth Rise in the demand for the drugs, advanced therapies and minimal invasive surgeries for the relive of the patients are driving the growth of the market.

    Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1118

    The Back bone is made up of spinal nerves which runs down from the neck to the lower back. The spinal cord acts as a mediator which sends and receives signals from the brain to the rest of the parts of the body. The spinal cord is a very delicate and so it is protected by the vertebrae and the fibrous tissues. Certain compressions in the spinal cord can cause deformities in the vertebra and cause radiculopathy. Radiculopathy is a condition caused due to the compression in the nerve root which produces weakness and pain across the length of the nerve. The compression in the nerve can occur at cervical, thoracic and lumbar region of the spine. The lumbar or the lower back radiculopathy is called sciatica moreover it is the most affected region.  

    The symptoms of cervical radiculopathy occurs due to the sensations in arms and hands due to the pinched nerve root in the neck. The thoracic or the upper back region is the least common area for radiculopathy. It can be caused due outgrowth of the bone as in the case of osteoarthritis, infections, tumours, thickening of the spinal ligaments, abnormal curvature of curve due to scoliosis and spinal herniation or slip discs. The Pain caused due to radiculopathy can be felt either at the nerve injury site or at the arms and legs far away from the point of injury. The sensations can be felt in the neck, lower back, thorax, arms or legs.

    Request Full Report with TOC: https://www.factmr.com/report/1118/vertebral-radiculopathy-market

    Geographically, the global vertebral radiculopathy market is segmented into five key regions, namely North America, South America, Europe, and Asia Pacific excluding Japan, Japan and Middle East & Africa. North America followed by Europe is the dominant market of vertebral radiculopathy due to technological advancement, infrastructure and better health care facilities. On the other hand, Asia pacific is expected to grow during the forecast period due to the rise in the ageing population suffering from osteoarthritis and increasing government initiatives. Moreover the manufacturers are investing on the vertebral radiculopathy drugs due to huge demand by the patients.

    Examples of some of the key players in the global vertebral radiculopathy market are Bayer AG, Atnahs, Taisho pharmaceutical co.,ltd., Almatica Pharma, Inc. Canton Laboratories, LLC, etc. Acquisition, mergers, strategic collaborations, and technology plays a vital role in the growth of vertebral radiculopathy market

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=1118

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 29, 2018 ) Asia-Pacific advanced visualization (AV) market
    Advanced visualization (AV) systems are medical instruments, equipped with advanced software that display the numerous aspects of living cells efficiently. They are new-generation data visualization platforms that help end users to view data in depth by providing enhanced image quality. These help specialists by providing a better understanding of various clinical issues, thus, leading to faster and higher quality healthcare. It is widely utilized in most pathological laboratories as well. They also help in targeted drug therapy, ultimately reducing the cost of the procedure. The Asia-Pacific AV market is expected to reach USD Bn by 2023 with a compound annual growth rate (CAGR) of 13.44% during 2018-2023.

    The key competitors in the Asia-Pacific AV market are Toshiba Corporation, Ziosoft, Koninklijke Philips N.V., Afga-Gevaert, Conmed and others.

    Get Free Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-NTS-HnM-125341

    The market is divided into three primary segments based on the types of product, solution and imaging modality.
    Based on the types of product, the market is segmented into hardware and software and services.
    Based on solution, the market is segmented into enterprise-wide thin client-based solution and standalone workstation-based solution.
    Based on imaging modality, the market is classified into magnetic resonance imaging (MRI), positron emission tomography (PET), computer tomography (CT), ultrasound and x-ray.
    On the basis of countries, the market is segmented into China, Japan, India, and rest of Asia-Pacific (APAC).

    Key growth factors
    Asia-Pacific represented more than half of the world's population in 2016, and with the population still increasing, the demand for efficient and early diagnosis of diseases like cancer is growing continuously. The rise in disposable income as well as an increase in awareness about advanced diagnostics will drive the market. There has been a massive rise in chronic diseases in the APAC region over the past decade, mainly cancer, cardiac and neurological disorders due to increased tobacco use, alcohol consumption, etc. Using AV is one of the best ways for early detection, diagnosis and treatment of these diseases.

    Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-NTS-HnM-125341

    Threats and key players
    The APAC region has a significant disparity among its various countries regarding access to healthcare facilities. Although countries such as Australia and Japan have excellent medical infrastructure and imaging technology, countries such as Bangladesh, Nepal, Afghanistan have subpar facilities. This could hamper the AV market from developing in those countries. The use of AV is complex and may require the assistance of service specialists or specialized training, which can be costly. This can hinder the growth of the market. The price of the AV tools is very high and many of the APAC countries like Bangladesh, Pakistan and Afghanistan may not be able to afford them due to poorer economic conditions prevailing in those regions, which can constrain the market.

    What’s covered in the report?
    1. Overview of the Asia-Pacific AV learning market.
    2. Market drivers and challenges of the Asia-Pacific AV market.
    3. Market trends in the Asia-Pacific AV market.
    4. Historical, current and forecasted market size data for the segment based on the product type - hardware and software and services.
    5. Historical, current and forecasted market size data for the segment based on solution - enterprise-wide thin client-based solution and standalone workstation-based solution.
    6. Historical, current and forecasted market size data for the segment based on imaging modality - magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computed tomography (CT) and x-ray.
    7. Historical, current and forecasted country-wise (China, Japan, India and rest of APAC) market size data for the AV market.
    8. Historical, current and forecasted market size data for country-wise segments.
    9. Analysis of the company profiles of major competitors operating in the market.

    Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-NTS-HnM-125341/

    Why buy?
    1. Understand the demand for AV to determine the viability of the market.
    2. Identify the challenge areas and address them.
    3. Develop strategies based on the drivers, trends and highlights.
    4. Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
    5. Recognize the key competitors of this market and respond accordingly.
    6. Knowledge of the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
    7. Define the competitive positioning by comparing the products and services compared with the key players in the market.


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Advancement in endovascular operative techniques has facilitated treatment of wide range of intracranial aneurysms. Stent-assisted coiling is one of the minimally invasive technique in the treatment of a wide-necked intracranial aneurysm. Stents are used as scaffolds to assist coil embolization in stent-assisted coiling procedures. Stent-assisted coiling involves placing a stent inside of wide neck aneurysm to fix coil that protects damaged blood vessel walls.

    Get Free Sample Report here- https://www.factmr.com/connectus/sample?flag=S&rep_id=1135

    Nowadays, Stent-assisted coiling can be highly performed procedure for the ruptured aneurysm. However, the stent-assisted coiling diminishes the risk of stent-associated thromboembolic complications, antiplatelet therapy. Many healthcare practitioners considered stent-assisted technique as renderings technique for exposing of elevated risk of bleeding related complication if any complex surgery is consequently required. According to brain aneurysm foundation, 6 million people in the U.S. have the unruptured brain aneurysm or about 30,000 people suffer from brain aneurysm rupture.

    Stent-Assisted Coiling Market: Drivers and Restraints-

    Increasing prevalence of an aneurysm and intracranial disorder the major factors which expected to drive Stent-Assisted Coiling Market. Technology advancement, improvement in healthcare facilities, adoption of new surgical options are expected to boost the global stent-assisted coiling market. Adoption stent-assisted coiling over coiling, raising awareness, improvement in reimbursement scenario is driving the stent-assisted coiling market. The stent-assisted coiling market is expected to show significant growth rate in forecast period due to increasing government initiatives and adoption of minimally invasive surgical procedures. However, factor such as high cost of surgical procedures, complex surgery, and lack of skilled or experienced professionals for performing surgery is restraining the growth of the global stent-assisted coiling market.

    Stent-Assisted Coiling Market: Segmentation

    On the basis of product type, stent-assisted coiling market can be segmented as:

    Self-Expandable Stents
    Liquid Embolic Devices
    Flow-diversion devices
    Embolic Coils
    On the basis of the end user, the cardiac mapping system market can be segmented as:

    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Stent-Assisted Coiling Market: Overview

    An aneurysm is a complex intracranial endovascular disease. A brain aneurysm is the reason of 5,00,000 deaths each year worldwide and half of the sufferer are younger than 50. Stent-assisted coiling is the much less invasive procedure to repair the ruptured aneurysm. Two main self-expandable stents, Neuroform and enterprise stent are usually used for stent-assisted coiling of complex intracranial aneurysms. Stent assisting coiling to ease the endovascular treatment of a wide-neck intracranial aneurysm. Introduction of new surgical procedures techniques, increasing adoption of minimally invasive surgeries, increasing healthcare expenditures are expected to boost the stent-assisted coiling market.

    To know more about the Stent-Assisted Coiling Market Trends, visit this link- https://www.factmr.com/report/1135/stent-assisted-coiling-market

    Stent-Assisted Coiling Market: Region-wise Outlook

    In terms of geography, cardiac mapping system market has been divided into eight regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding China & Japan (APECJ), China, Japan, Middle-East & Africa and Latin America. North America is the most dominating market for stent-assisted coiling market due to increasing healthcare expenditure and increasing adoption of stent-assisted coiling surgery. Western Europe like Germany, France, and the UK is another fastest growing region in the stent-assisted coiling market due to growing healthcare practices and development of healthcare facilities. APECJ region includes two fastest developing countries India and China, which provide the most promising market for stent-assisted coiling market players. Due to factors like increasing awareness, rapid improvement in healthcare services, large population pool and increased prevalence of intracranial diseases.

    Stent-Assisted Coiling Market: Key Market Participants

    Example of some key market participants in global stent-assisted coiling market identify across the value chain are DePuy Synthes, Medtronic Plc, MicroPort Scientific Corporation, Stryker Corporation, OBEX Medical Limited. Some of the other companies having the significant presence in the global stent-assisted coiling market are Abbott Laboratories, ADMEDES GmbH, Balt Extrusion, Cardiatis and Penumbra, Inc. Global market players are introducing new products with better efficiency to create good market opportunities for the stent-assisted coiling market. Rising number of mergers and acquisitions, increasing number of collaborations and partnerships are key trends that are observed in the global stent-assisted coiling market.

    The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current, and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    Grow Your Business From Expert Advice- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1135

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Sutures are widely used materials in wound closure. Sutures are commonly known as stitches or surgical threads which are used to repair cuts. Sutures are used to hold the skin, tissues of the human body and blood vessels. There are many kinds of sutures such as absorbable and non-absorbable sutures. Absorbable sutures break down after a period of time as the wound heals. Polygyconate sutures are monofilament absorbable synthetic sutures used for extended wound healing for about six weeks. Polygylyconate sutures are copolymers of glycolic acid and trimethylene carbonate. Synthetic polyglyconate sutures are used for general soft tissue approximations or ligation and in peripheral surgery.

    Get Free Sample Report here- https://www.factmr.com/connectus/sample?flag=S&rep_id=1136

    Monofilament sutures generally provide a better passage through tissues and elicit lower tissue reaction compared to braided sutures. Polyglyconate sutures have the strongest initial tensile strength of all the other types of sutures and residual strength decreases rapidly. Polyglyconate sutures are preferred in gastrointestinal surgery and in surgery of congenital heart defects. The advanced extrusion process of the polygyconate molecules gives sutures in-vivo strength retention, knot trying security excellent handling and minimal memory.  Polyglyconate sutures have advantage over other sutures such as lack memory, pass easily through tissues, improved handling properties and demonstrate superior strength.

    Polyglyconate Sutures: Market Dynamics

    Increase in number of surgical procedures owing to increasing chronic disease and technological advancement in the usage of various kind of surgical sutures are expected to drive the growth of the polyglyconate sutures market. New product launch and increasing demand for cosmetic surgeries propel the polygyconate sutures market. Increased disposable income is the major factor that contributes towards the growth of the polyglyconate sutures market. However, increase demand for minimally invasive surgical products, improper sterilization system, and lack of skilled professionals in developing countries hinder the growth of the polyglyconate sutures market globally. Side effect caused by sutures is major barrier in polyglyconate sutures market.

    Polyglyconate Sutures Market: Segmentation

    The global polyglyconate sutures market is segmented on basis of application, end users and geography.

    Segmentation by Application
    Cardiovascular Surgeries
    General Surgeries
    Gynecological Surgeries
    Orthopedic Surgeries
    Others
    Segmentation by End Users
    Hospitals pharmacies
    Specialty Clinics
    Emergency Medical Services
    Ambulatory Surgical Centers
    Segmentation by Geography
    North America
    Latin America
    Europe
    Asia-Pacific Excluding China
    China
    Middle East & Africa
    Polyglyconate Sutures Market: Overview

    On the basis on application, the cardiovascular surgeries segment accounts for a large share in the polyglyconate sutures market due to increase in cardiac disease patient pool owing to unhealthy lifestyle. General surgeries show significant growth owing to number of accidents. 

    To know more about the Polyglyconate Sutures Market Trends, visit this link- https://www.factmr.com/report/1136/polyglyconate-sutures-market

    On the basis of end users, the hospital segment shares a large share owing to increase in number of surgeries such as cardiovascular surgeries. Growing popularity in cosmetic surgeries and increase in chronic disease contribute in the share of hospitals in end users segment. Specialty clinics segment shows significant growth in the polyglyconate sutures market.

    Polyglyconate Sutures Market: Region-wise Outlook

    The North America market for polyglyconate sutures holds a large revenue share owing to presence of major key players, higher adoption of technologically advanced products and increase in prevalence of chronic disease. Rising number of surgeries and augmenting demand for advanced treatment procedures propel the market of polyglyconate sutures market in North America. Europe accounts for the second large revenue share in the polyglyconate sutures market owing to developed healthcare infrastructure, good reimbursement policies. Asia Pacific is expected to witness rapid growth owing to increase in medical tourism, improved healthcare infrastructure, large patient pool suffering from cardiovascular disease, coronary thrombosis and others and low cost of treatment and increase prevalence of lifestyle disease. China is expected to show significant growth owing to increase geriatric population and increase in disposable income. Latin America and Middle East & Africa are expected to show slow growth owing to lack of awareness among population and less developed healthcare facilities.

    Polyglyconate Sutures Market: Key Players

    Examples of some of the key players present in the global polyglyconate sutures market are Medtronic Plc, Lotus Surgicals, and others.

    The report covers exhaustive analysis on:

    Polyglyconate Sutures Market Segments
    Polyglyconate Sutures Market Dynamics
    Historical Actual Market Size, 2012 - 2016
    Polyglyconate Sutures Market Size & Forecast 2016 to 2024
    Polyglyconate Sutures Market Current Trends/Issues/Challenges
    Competition & Companies involved
    Polyglyconate Sutures Market Drivers and Restraints
    Regional analysis includes

    North America
    Latin America
    Europe
    Asia Pacific Excluding China
    China
    Middle East & Africa
    Report Highlights:

    Shifting Industry dynamics
    In-depth market segmentation
    Historical, current and projected industry size Recent industry trends
    Key Competition landscape
    Strategies of key players and product offerings
    Potential and niche segments/regions exhibiting promising growth
    A neutral perspective towards market performance
    Grow Your Business From Expert Advice- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1136

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Bio-identical hormones which are in great use because of its efficiency and conventional approach is forming a new range in clinical operations through which a person is cured. Bio-identical hormones replacement therapy uses hormones which are very similar to the hormones produced by the human body and are used as a treatment for hormones deficiency. This procedure requires a brief study of the human body in order to obtain sustainable data to produce pre-made bio-identical hormones on prescription or are compounded by a pharmacist, based on the doctor’s diagnosis. Bio-identical hormones replacement therapy offers less risk compared to other conventional hormone therapy.

    Get Free Sample Report here- https://www.factmr.com/connectus/sample?flag=S&rep_id=1137

     But regular synthesized bio-identical hormones not necessarily have to be a custom-compounded (custom-mixed) product in order to develop the result, as there are commercially available bio-identical products that meets the definition and are commercially available. Mostly the bio-identical hormones replacement therapy involves products in order to be in use for the treatment of symptoms and related complications of menopause such as, night sweats, mood changes, weight gain, vaginal dryness, mood changes, fatigue, hot flashes etc. Bio-identical hormones replacement therapy however is affected with side effects such as increased risk of heart attack, breast cancer, stroke, etc. and does not come out as an ideal replacement for the conventional approach                               

    Bio-identical Hormones Replacement Therapy Market: Drivers and Restraints

    Bio-identical Hormones Replacement Therapy uses a simple theory of extracting hormones which are made on pre-prescription and are observed to be in use majorly for the complications associated with menopause. Bio-identical Hormones Replacement Therapy Market is rising and being affected with increasing geriatric population, rising awareness, healthcare reforms, growing screening for hormonal deficiency, and growing financial stability in women etc. The market for Bio-identical Hormones Replacement Therapy is restricted regarding their use, low healthcare expenditure in developing regions, side effects of most hormonal therapies, costs considerations, etc.

    Bio-identical Hormones Replacement Therapy Market: Overview

    The global market Bio-identical Hormones Replacement Therapy is consolidated with several players operating in the global space. Combined approaches of using Bio-identical Hormones Replacement Therapy with better technological advancements to omit the undue problems while using a system is expected to create a high demand. Some of the established brands of Bio-identical

    Bio-identical Hormones Replacement Therapy Market: Regional Wise Outlook

    Geographically, the Bio-identical Hormones Replacement Therapy Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China and Japan, Japan, China, Middle East and Africa. The North America account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the bio-identical hormones replacement therapy market. Western Europe is the second largest market in the world due to high income and healthcare penetration. Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. Gulf nations such as Saudi Arabia and the UAE are projected to drive the Middle East & African market, moderate growth is expected owing to poor economic and healthcare development. China is expected to take a progressive step in the market for global Bio-identical Hormones Replacement Therapy Market throughout the forecast period due to its reformed healthcare policies and public initiatives to cut down the prevalence rate.

    To know more about the Bio-identical Hormones Replacement Therapy Market Trends, visit this link- https://www.factmr.com/report/1137/bio-identical-hormones-replacement-therapy-market

    Bio-identical Hormones Replacement Therapy Market: Key Players

    Examples of some of the major players in the global Bio-identical Hormones Replacement Therapy Market are SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Inc., Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Biostation are some of the key players operating in this market. Technological advancement in already marketed products is the major trend emerging in the global Bio-identical Hormones Replacement Therapy Market.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes

    North America (U.S., Canada)
    Latin America (Mexico, Brazil)
    Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
    Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
    Asia Pacific Excluding Japan and China (India, Australia & New Zealand, ASEAN)
    Japan
    China
    Middle East and Africa (GCC, S. Africa, Rest Of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint.
    Grow Your Business From Expert Advice- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1137

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) The human body comprises of several different kind of charged ions in order to provide energy and movement of signals throughout the body. Chloride is one of the most important essential electrolytes present in the body, with an abundance of above 60% of the entire negatively charged ions content. It is highly important to keep a regular balance between fluid and acid within the body to avoid any complications. Chloride is occasionally performed by itself but instead usually in conjunction with other electrolytes.

    Get Free Sample Report here- https://www.factmr.com/connectus/sample?flag=S&rep_id=1138

    Body can face a low circulating level of chloride associated with gastrointestinal problems or salt-losing nephritis. Increased level of concentration is also observed often with dehydration, renal tubular acidosis, and acute renal failure. Proper amount of chloride is also responsible for the formation of hydrochloric acid which is present in the stomach for proper digestion and absorption of protein and minerals for a healthy life. Composition of such ions are responsible for many such activities for crucial functioning of nerves, muscles and the excretion and absorption of bodily fluid.      

    Chloride Reagents Kits Market: Drivers and Restraints

    The observed chloride present in the body usually provides a good reference for a diverse clinical remarks, balanced chloride content present in the body helps in maintaining a good ion concentration which helps in following a better stimulation of signals for transferring messages across the body. CNS is responsible for the transfer of impulses carrying signals and loss of chloride may affect the regular functionality of the CNS system. Gastrointestinal juices or acid is also a form that is formed with the help of chloride present in the body and may affect the functions of it in case of any imbalance in the composition.  All these factors provide a better and reformed take in manufacturing chloride reagent kits with better approach and few of the failed clinical testing’s provide a chance of improvement in the preparation of reagents through different composition.

    Chloride Reagents Kits Market: Segmentation

    Tentatively, the global Chloride Reagents Kits Market has been segmented on the basis of product type, services, application and geography.

    Based on application, the global Chloride Reagents Kits market is segmented as:

    Hospital
    Clinic
    Forensic center
    Research institutes
    Chloride Reagents Kits Market: Overview

    The global market for Chloride Reagents Kits is highly consolidated with several local and major players operating in the global space. Combined approaches of using a better Chloride Reagents Kit with better technological advancements to omit the undue errors while performing a clinical test is expected to create a high demand for Chloride Reagents Kits in safety applications. Some of the established brands of Chloride Reagents kits are Hanna Instruments, Inc, Merck KGaA, Lanxess AG, Transpek Industries Ltd. Aurora Fine Chemicals LLC, CABB Group, Thermo Fisher Scientific and more.

    To know more about the Chloride Reagents Kits Market Trends, visit this link- https://www.factmr.com/report/1138/chloride-reagents-kits-market

    Chloride Reagents Kits Market: Regional Wise Outlook

    Geographically, the global Chloride Reagents Kits market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in global Chloride Reagents Kits market owing to the growing healthcare reforms and investments, increase in better approaches towards the healthcare facilities also make a shift towards a better market. The market in Asia Pacific excluding Japan and China is expected to grow at significant CAGR due to the unmet healthcare needs and with rising awareness campaigns, expansion of product offerings by key players is predicted. China is expected to take large share in the global Chloride Reagents Kits market throughout the forecast period due to its reformed healthcare policies and local manufacturer’s cheap product offerings.

    Chloride Reagents Kits Market: Key Players

    Examples of some of the major players in the global Chloride Reagents Kits market are Hanna Instruments, Inc, Merck KGaA, Lanxess AG, Transpek Industries Ltd. Aurora Fine Chemicals LLC, CABB Group, Thermo Fisher Scientific and more.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes

    North America (U.S., Canada)
    Latin America (Mexico, Brazil)
    Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
    Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
    Asia Pacific Excluding Japan and China (India, Australia & New Zealand, ASEAN)
    Japan
    China
    Middle East and Africa (GCC, S. Africa, Rest Of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    Grow Your Business From Expert Advice- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1138

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=61

    As per the latest report published by Fact.MR, the Global OTC Vitamins and Dietary Supplements Market is poised to increase at a CAGR of 6.7% between 2017 and 2022. A positive outlook on the role of OTC vitamin and dietary supplement products in improving body endurance and muscular strength is characterizing the widespread acceptance of such products. Also, the growth of the healthcare sector and introduction of favorable government policies focused on the development of healthcare is partly responsible for the increasing popularity of various over-the-counter (OTC) drugs including vitamins and dietary supplements. A notable growth in demand for OTC vitamins and dietary supplements has been observed in emerging countries such as China, Brazil and India due to increasing awareness among consumers about the benefits of such products. In addition, factors such as self-medication in cases of minor health issues, cost-effectiveness, and convenience of direct purchase are anticipated to drive the adoption and acceptance of OTC vitamins and dietary supplements over the next couple of years. Besides, drug makers are now concentrating on innovation in the formulation of such products in order to increase their functionalities. 

    North America’s Leadership in Global OTC Vitamins and Dietary Supplement Market to Remain Unchallenged

    The market for OTC vitamins and dietary supplements in North America is expected to remain highly lucrative during the forecast period. Currently, the region accounts for the largest share of the global market in terms of value. This is primarily owing to soaring demand for OTC drugs particularly in the U.S. Meanwhile, the market in Asia Pacific excluding Japan (APEJ) is also expected to witness an impressive growth over the forecast period (2017-2022). By 2017-end, Europe is estimated to account for more than 31% revenue share of the global market.

    By function, use of OTC vitamins and dietary supplements will be robust for the general well-being of the body. Throughout the forecast period, global revenue from sales of OTC vitamins and dietary supplements for general well-being will continue to exhibit strong growth.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market

    Pharmacies will remain the leading OCT channel for OTC vitamins and dietary supplements in 2017 and beyond. Pharmacies currently account for more than one-fourth share of the global market in terms of revenue. However, this OTC channel segment of the market is expected to lose 141 BPS toward the end of the forecast period.

    Based on product form, global sales of OTC vitamin and dietary supplements capsules are expected to remain relatively higher over 2022.  Close to US$ 33 Bn worth of capsules are expected to be consumed worldwide by the end of the forecast period.

    Competition Tracking

    The global OTC vitamins and dietary supplements market remains highly competitive with several leading companies partaking in it, which include BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Sanofi S.A., Pfizer, Inc., GlaxoSmithKline plc, Dil Limited., Reckitt Benckiser LLC, CSPC Pharmaceutical Group Limited., Otsuka Holdings Co. Ltd., and Bactolac Pharmaceutical, Inc.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=61

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Ultrasound systems are imaging devices that employ high-frequency sound waves for capturing live images from inside of the patient’s body. Ultrasound as a scanning method is often synonymous to sonography. Ultrasound systems are predominantly used in pregnancy diagnostics, but these systems can also procure accurate images in all other fields of diagnostics as well. Precise medical imaging has a controlling influence over the efficacy of subsequent procedures, which is why medical professionals continue to prefer accurate imaging methods such as ultrasound.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=60

    The FactMR report on global market for ultrasound systems accedes to this notion, projecting a steady growth in the global demand for ultrasound systems during 2017-2022. According to the report, the Global Ultrasound Systems Market will reach US$ 6 Bn value by the end of 2017. Ultrasound imaging systems will continue to gain ground due to their affordable costs and higher accuracy, particularly for diagnostic imaging during pregnancy. Towards the end of 2022, the global ultrasound systems market value is anticipated to soar steadily at 5.5% CAGR, bringing in revenues worth over US$ 7.8 Bn.

    Ultrasound makes Headway in Cardiology

    The report reveals that ultrasound systems are paramount in gynecological imaging, even so a major share of ultrasound systems sold globally are accounted by cardiology diagnostics. Rising incidence rate of myocardial infarction and angina in the world is making the use of ultrasound systems imperative in the field of cardiology. Between 2017 and 2022, the global sales of ultrasound systems in cardiology applications are expected to create an incremental opportunity of more than US$ 430 Mn.

    Standalone Ultrasound Systems to Remain Indispensable

    Portability of ultrasound systems is becoming a governing factor for boosting its global sales. Preference to portable ultrasound systems will be distinctly high across all medical settings. During the forecast period, global revenues accounted by sales of portable ultrasound systems are anticipated to exhibit growth at a surging CAGR of 6.4%. While portable ultrasound systems will mark a little over 17% share on global revenues through 2022, the market will continue to witness foremost demand for standalone ultrasound systems. In 2017, the global market for ultrasound systems is pegged to rake in revenues worth over US$ 4.2 Bn, exclusively from the sales of standalone ultrasound systems.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/60/ultrasound-systems-market

    High Demand across Radiology Departments in Hospitals

    Ultrasound is staple imaging technology in independent radiology centers as well as radiology departments in hospitals. With increasing demand for radiotherapy, the adoption of ultrasound systems is slated to rise across all general hospitals. The report observes hospitals as the largest end-user of ultrasound systems in the global market, projecting that this segment will account for approximately 50% of the global market revenues through 2022. Diagnostic centers are also expected to account for greater end-use of ultrasound systems in the global market. By the end of 2022, more than US$ 1.5 Bn worth of revenues will be reaped from global sales of ultrasound systems in diagnostic centers.

    Competitive Tracking

    The report has profiled leading manufacturers of ultrasound systems as the key players in the market. With advancements in imaging technologies, manufacturers are expected to focus more on offering ultrasound systems with more integrated features. Companies such as Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Hitachi Ltd., Siemens AG, Shimadzu Corporation, Analogic Corporation, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd., and Esaote SpA are likely to be observed as active participants in the global ultrasound systems market during the forecast period.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=60

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) A syringe is a medical device used for injecting fluids into the body, or to withdraw fluid from the body. A typical medical syringe has a needle attached to a hollow cylinder, which is fitted with a sliding plunger. By pushing the plunger in downward movement, the fluids are injected in a body, and retracting the plunger in upward direction extracts fluids from the body.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=59

    Invasive nature of medical procedures might frighten patients at first, but injecting medications turns out to be the healthier option over tropical application or oral intake. Supporting this notion, syringes continue to be a key product in the healthcare industry, offering optimum drug administration with minimal discomfort. Concurring to such particulars, the Fact.MR report on Global Syringe Market predicts that the global demand for syringes will continue to surge in the years to come. 

    According to the report, more than US$ 11 Bn worth of syringes will be sold in the world by the end of 2017. With increasing advancements in drug administration techniques, surgical industries will witness the emergence of new, multifunctional syringes, which will incidentally have a promising influence on the Growth of Syringes Market. Through 2022, the global market for syringes will have soared at 7.8% CAGR, procuring revenues worth more than US$ 16.5 Bn.

    Higher Surgical Preference to Specialized Syringes

    Easy usability of standard syringes have made them a household commodity as consumers are attaining proper training, and administrating common vaccines by themselves. Meanwhile, medical organizations are prompting surgeons & medical practitioners towards higher adoption of specialized syringes. Unlike standard syringes, their specialized counterparts are successfully lowering healthcare costs by performing multiple injection functions at the cost of a single syringe. While their influence in cutting the medical bills of patients is marginal, specialized syringes are certainly drawing more adoption for their effectiveness.

    In 2017 and beyond, more than 30% of global syringes market will procure its value through global sales of specialized syringes. The report, however, doesn’t understate the dominance of general syringes in the global market. With the largest revenue share, general syringes are expected to contribute more than US$ 3.5 Bn revenues to the global market by the end of 2022.

    Browse here complete details about Report: https://www.factmr.com/report/59/syringes-market

    Disposable Plastic Syringes to Gain Traction

    Key findings from the report also reveal that more than 99% of the global syringe sales will be accounted by plastic as raw material. Polymer syringes will continue to gain surplus demand, compared to glass syringes, indicating a clear-cut preference for surgical instrument manufacturers. The report also projects a significant rise in demand for disposable syringes. According to the report, more than 80% revenues procured in the global market will come from sales of disposable syringes. Higher health risks of reusing syringes is also attesting this projection, inferring a relatively sluggish growth in global sales of reusable syringes during the forecast period.  

    The report also projects that hospitals will be observed as the largest end-users of syringes. While hospitals will certainly dominate over diagnostic centers, considering their treatment capacities, the report expects that over 66% of revenues amassed in the global syringe market will be accounted by hospitals. The report also projects that blood collection centers will contribute to more than US$ 1.8 Bn revenues by the end of the forecast period. Diabetic care centers are also expected to remain an attractive segment in terms of end-use. By the end of 2022, close to US$ 800 Mn worth of syringes will be sold through diabetic care centers in the world.

    Competition Tracking

    The report has also profiled leading players in the global market for syringes, which include companies such as B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Terumo Corporation, Hindustan Syringes & Medical Devices Limited, Nipro Corporation, Medtronic PLC, Schott AG, Codan Medizinische Geräte GmbH & Co Kg, and Schott AG.

    For any query get easily connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=59

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Uncontrollable growth of cells in prostate gland leads to the development of prostate cancer. Several men develop low-grade prostatic intraepithelial neoplasia (PIN), however they don’t necessarily develop prostate cancer. No sure way has been found to prevent prostate cancer, however the chances can be lowered by being physically active and maintaining a healthy weight.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=58

    An increasing geriatric population across the developed world along with access to top-quality healthcare is expected to benefit the Prostate Cancer Diagnostics Market. Healthcare spending is growing by leaps and bounds both though the government as well as private providers. As per the WHO Health Spending Observatory, the spending on health may rise to US$ 18.2 trillion by the year 2040 with annual growth rates of 3.4% in upper middle income countries and 2.7% in high-income ones. The global prostate cancer diagnostics market is projected to grow to nearly US$ 1.1 billion in 2022.

    PCA3 and PSA Test Segment Vital in the Prostate Cancer Diagnostics Market

    The PCA3 and PSA test segments can be considered the most important in the prostate cancer diagnostics market as they both represent the highest potential in terms of market opportunity. The PSA segment is anticipated to be worth just over US$ 270 million in 2017 and it should grow at a healthy CAGR during the period 2017-2022. On the other hand, the PCA3 segment is poised to grow to nearly US$ 284 million by the end of the forecast period.

    North America is the largest region for both segments and accounts for nearly 2/5th of the prostate cancer diagnostics market. The region’s large geriatric population and high prevalence of cancer mean that demand for prostate cancer diagnostics will continue to remain strong during the forecast period.

    Smaller Share of CTC

    The CTC segment holds revenue share in the global prostate cancer diagnostics market. This segment is projected to reach US$ 141 million by the end of 2022.

    The immunohistochemistry segment is projected to witness a CAGR of 4.5% for the five-year study period. While North America may be the largest regional contributor, key stakeholders could also focus on Europe as it holds a revenue share of more than 30% throughout the period.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/58/prostate-cancer-diagnostics-market

    Focus on Hospital Labs and Research Institutes

    The hospital associated labs segment is assessed to grow significantly during the forecast period. It would make sense for companies to focus on cancer research institutes as collaboration can help in the development of innovative solutions. In this case, companies could think of targeting the APEJ region as it has the highest CAGR during the forecast period. The region spends much less on healthcare as a percentage of GDP than the developed world but strong economic growth will all but ensure that it becomes ever-more important to regional governments in future.

    Competition Tracking

    Key players in the global market for prostate cancer diagnostics include Abbott Laboratories, Biocept, Inc., AstraZeneca plc., Cancer Genetics, Inc., Danaher Corporation, Bayer Aktiengesellschaft, Becton, Dickinson and Company, Agilent Technologies, Foundation Medicine, Inc., and Myriad Genetics Inc.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=58

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. This cancer originates in two principal locations of the kidney – the renal pelvis and the renal tubule.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=57

    A new report published by Fact.MR estimates the global Kidney Cancer Diagnostics Market to exhibit an impressive expansion at during the forecast period 2017 to 2022. In terms of revenues, the global market for kidney cancer diagnostics will reach nearly US$ 700 Mn by 2022-end.

    Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression

    Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.

    Kidney cancer has been witnessed to occur majorly in older population. Diagnosis of kidney cancer becomes an intricate task, considering the condition of geriatric patients. While staple diagnostic technologies such as MRI and CT scan continue to play a pivotal role in the global market, patients are also expecting the emergence of all-inclusive diagnosis tests. Medical organizations are also funneling high investments in R&D of kidney cancer diagnostics, particularly to improve the precision of early stage diagnosis tests. Through advancements in medical technology, the global market for kidney cancer diagnostics is also expected to witness emergence of new tests that can simultaneously decelerate the pace of tumor maturation between multiple stages of kidney cancer.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/57/melanoma-cancer-diagnostics-market

    Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics

    On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global Kidney Cancer Diagnostics Market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.

    Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.

    Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.

    North America to Remain the Largest Market for Kidney Cancer Diagnostics

    In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.

    Competition Tracking

    Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=57

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Breast cancer is a cancer that develops when cells and tissues in the breast begin to grow out of control. Usually forming into a tumor, breast cancer is visible as a lump surrounding the internal breast tissues. Breast cancer tumor is malignant, and occurs almost entirely in women, apart from exceptional occurrences in men. Fact.MR, in its latest report, estimates the Global Breast Cancer Diagnostics Market to register a moderate expansion at 4.7% CAGR during the forecast period 2017 to 2022.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=55

    Screening Practices of Breast Cancer Witnessed to Alter Early Detection Practices

    Breast cancer has become the most common type of cancer for women across the globe. The number of women suffering from breast cancer is witnessing a surge. This has led towards necessity for efficient early detection of breast cancer. Mammography screening, an established method adopted across several countries, has been recently been observed to offer inconclusive test results. Risk-adapted, personalized therapy and screening are predicted to resolve these difficulties. In addition, tomosynthesis, a new imaging technology, has been seen to overcome the drawbacks of mammography.

    Screening options for breast cancer have been witnessing a rise, and have been altering practices of early detection across industrialized economies. Moreover, countries such as Brazil, India and China are focusing on development of cost-effective screening strategies capable of being adapted as per requirements.

    Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

    The global Breast Cancer Diagnostics Market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

    By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

    Browse here complete details about Report: https://www.factmr.com/report/55/breast-cancer-diagnostics-market

    Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

    Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

    Competition Tracking

    Key market players mentioned in Fact.MR’s report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

    For any query get easily connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=55

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Bone growth stimulators are supplemental medical devices worn by patients following a cervical or lumbar spine surgery. Bone growth stimulators are utilized in boosting the natural fusion of spinal bone after fracture. Advanced bone growth stimulators can also facilitate multi-level fusions, the efficiency of which plays a pivotal role in spine fusion aftercare of patients. 

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=54

    A latest report by Fact.MR projects the global Bone Growth Stimulators Market to account for revenues worth US$ 1,477.2 Mn in 2017. The market is estimated to exhibit a steady expansion during the forecast period. Various devices are developed for bone growth stimulation therapy, which are being highly demanded on the back of growing cases of accidental bone injuries across the globe.

    Rise in R&D Funding by Private Organisations to Propel Growth of the Global Bone Growth Stimulator Market

    Bone growth stimulators facilitate multi-level fusions in bones with high efficiency, playing a pivotal role in spine fusion aftercare of patients. Medical studies are revealing positive outcomes of utilizing electrical bone growth stimulators for spinal fusion process. With a number of favorable government initiatives, coupled with heavy investments made by several private organisations, there has been a robust increase in research & development activities associated with new treatment methods and product development. For example – the North American Spine Foundation, and American Academy of Orthopedic Surgeons are contributing to the development of spinal implants & devices by raising funds for R&D activities, and conducting training programs for physicians worldwide.

    Leading players in the market have introduced novel bone growth stimulators in order to cater demand from soaring adoption of affordable minimally-invasive surgeries (MIS). Orthofix, a Texas Company, has introduced new bone growth stimulators, the CervicalStim and the SpinalStim, which have been approved by the European CE Mark as well as the Food and Drug Administration of the U.S. While the out-of-the-office treatment option (non-invasive) has an obvious appeal to it, necessary patient compliance remains a challenge for physicians. However, an application called Stim onTrack has been developed by Orthofix, which offers physicians with real-time data, which enables effective detailing of the patient’s treatment protocol.

    North America to Remain Dominant in the Global Bone Growth Stimulator Market

    North America will continue to be dominant in the global Bone Growth Stimulator Market. Sales of bone growth stimulators are expected to account for the largest revenues in North America, expanding at the highest CAGR through 2022. Europe will remain the second most lucrative market for bone growth stimulators. The market in Middle East & Africa (MEA) will continue to register a sluggish expansion through 2022.

    Bone growth stimulation devices will remain sought-after among products in the global market. Revenues from sales of bone growth stimulation devices will account for over half share of the market during the forecast period. In addition, sales of platelet-rich plasma bone growth stimulator, and bone morphogenetic proteins are expected to exhibit the fastest expansion registering similar CAGRs through 2022.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/54/bone-growth-stimulator-market

    Hospitals & Clinics will Remain the largest End-Users of Bone Growth Stimulators

    Based on end-users, sales of bone growth stimulators in academic and research institutes are expected to register the highest CAGR through 2022. Hospitals & Clinics will continue to be the largest end-users of bone growth stimulators, accounting for the highest share of the market over the forecast period. Home care is expected to remain the second most lucrative end-use segment in the global bone growth stimulators market.

    Bone growth stimulators are expected to find the largest application in the cases of delayed union & non-union bone fractures, with sales poised to reach US$ 763.4 Mn by 2022-end. Sales of bone growth stimulators in oral & maxillofacial surgeries will account for the lowest revenues during the forecast period, based on application.

    Competition Tracking

    The report has also profiled key players in the global market for bone growth stimulators, which include Ossatec Benelux B.V., Elizur Corporation, Johnson & Johnson, Arthrex, Inc., DJO Global Inc., Stryker Corporation, Bioventus Inc., Zimmer Biomet Holdings, Inc., Medtronic plc., and Orthofix International N.V.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=54

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Speech Generating Devices (SGDs), an assistive technology, are electronic augmentative & alternative communication (AAC) systems enabling individuals with severe speech impairments to verbally communicate. Organization, content, and updating vocabulary of SGDs are influenced by numerous factors such as patient’s requirements, and contexts in which the devices will be utilized. Several input and display methods of SGDs are available, including fixed display, dynamic display, and talking keyboards, for users with varying speech disabilities.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=53

    According to Fact.MR’s recent report, the Global Market for Speech Generating Devices is expected to register a staggering expansion at a CAGR of 12.2% during the forecast period 2017 to 2022. The report projects the revenues from global speech generating devices market to account for US$ 168.6 Mn in 2017; by 2022 this number is expected to reach nearly US$ 300 Mn.

    Market Players Concentrating on Enhancing Touch-Screen Devices for Easy Navigation of Speech Generating Devices

    A number of developments in the electronic technology over the past decade have enabled the speech generating devices to be portable and comparatively more user interactive. Several variants of speech generating devices are available on the basis of text, symbol system, cognitive abilities, physical abilities, tongue switches, and eye tracking system. Expansion of the global market for speech generating devices is mainly attributed to advancements in technology and rising availability of user-friendly devices. The National Institute of Deafness & Other Communication Disorders (NIDCD) has anticipated that approximately 7.5 Mn population in the U.S. is affected with speech-related disorders.

    Market players in the global speech generating devices market are concentrating on enhancing touch-screen devices to offer users with easy navigation. These manufacturers are enabling speech generating devices to connect with smart phones. Owing to speech generating devices’ portable nature, adoption of these devices is witnessing an upsurge among patients affected with speech-related disorders. This is further expected to pave tremendous opportunities for players in the global speech generating devices market. However, factors such as high cost and low penetration of speech generating devices are expected to curb growth of the market.

    North America to Remain the Most Lucrative Market for Speech Generating Devices

    North America is estimated to remain the most lucrative region in the global market for speech generating devices, followed by Europe. In North America, sales of speech generating devices is expected to account for revenues worth US$ 126.7 Mn by 2022-end. Speech generating devices market in Asia Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022.

    By product type, synthesized speech devices are expected to remain preferred in the global market for speech generating devices, followed by picture communicators. Text-to-speech devices’ sales are expected to exhibit the highest CAGR through 2022.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/53/speech-generating-devices-market

    Static Display for Speech Generating Devices to Remain Sought-After in the Market

    On the basis of display, even though speech generating devices with static display will remain sought-after, sales of speech generating devices with dynamic display will continue to exhibit a comparatively higher CAGR through 2022.

    Specialty clinics will remain dominant among distribution channels in the global speech generating devices market, witnessing expansion at the highest CAGR during the forecast period. Hospitals will remain the second most lucrative distribution channel for speech generating devices in the market, estimated to account for over US$ 100 Mn by 2022-end. Based on technology, manual segment will witness the largest adoption in the market, followed by eye tracking and head tracking technology-based speech generating devices.

    Competition Tracking

    Fact.MR’ report profiles key players in the global speech generating devices market, which include Abilia Toby Churchill Limited, AMDi, Saltillo Corporation, Zyteq Pty Ltd., Tobii Dynavox, Prentke Romich Company, Inc., Lingraphica, Textspeak, and Zygo USA.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=53

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 29, 2018 ) Patient positioning can be defined as methods in which patients are positioned on beds during medical operations. Appropriate ventilation, anesthesia management, physiologic safety of patients, optimal exposure to surgical site, and maintaining the patient’s dignity by controlling undue exposure of body parts are observed as the key fundamentals of patient positioning.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=52

    Surgical Tables Have the Largest Revenue Share Contribution

    The surgical tables segment accounted for 27% revenue share in the Patient Positioning Systems Market in the year 2017 which was higher than the 19% revenue share of tables segment. The surgical tables segment is poised to grow to almost half a billion by the end of 2022.

    Lesser Opportunity in Radiolucent Imaging and Examination Tables

    Radiolucent imaging is estimated to be a little over US$ 360 million by end 2022 and is on track to witness a steady CAGR of over 6%. North America accounts for approx. 40% of the radiolucent segment, and it is highly likely to retain this share for the rest of the study period. With respect to examination tables, a market opportunity of under US$ 200 million in 2017 might not seem very attractive initially but a CAGR of 5.2% for the five year period could be enough to sway major players to focus on this segment in the patient positioning systems market. The companies would be recommended to target Europe owing to the potential of emerging opportunities during the forecast period.

    Accessories and 'Other' Patient Positioning Systems Niche Segments

    With a revenue share of 12% and 7.7% in Accessories and Other patient positioning systems respectively, the two are undoubtedly niche segments in the patient positioning systems market. However, it would be unwise to ignore them entirely and manufacturers could focus on targeting North America in both cases as the region can present a significantly large market opportunity. The combined market value of the two segments in North America in the year 2017 could easily exceed US$ 100 million which manufacturers should take cognizance of while devising their investment plans. In both cases, North America alone accounts for roughly 2/5th of the patient positioning systems market.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/52/patient-positioning-market

    Ambulatory Surgical and Global Diagnostic Centres Remain Lucrative

    The market opportunity that exists in the ambulatory surgical centres and global diagnostic centres is quite similar. Ambulatory surgical centres were worth just over US$ 330 million in 2017 and may grow with a CAGR of 7.3% from 2017-2022. On the other hand, global diagnostic centres may near a value of half a billion dollars by the end of the forecast period which would be equal to a revenue share of 27%. Europe and North America dominate the global diagnostics centre segment of the patient positioning systems market as they comprise more than half the market opportunity.

    Competition Tracking

    The report has also outlined the competitive landscape of global market for patient positioning systems, which includes Mizuho OSI, LEONI AG, C-RAD, Elekta AB(publ), Skytron, Span-America Medical Systems, Inc., STERIS plc., Stryker Corporation, and Hill-Rom, Inc.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=52

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 29, 2018 ) Global Implantable Cardiac Devices Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Implantable Cardiac Devices. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Implantable Cardiac Devices market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Implantable Cardiac Devices Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-implantable-cardiac-devices-market-research-report-2018

    With this Implantable Cardiac Devices Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, Livanova (Sorin), Medico, Imz, Pacetronix, Qinming Medical, Cardioelectronica, Ccc and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1355665

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Implantable Cardiac Devices Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1355665

    List of Chapters:
    1 Implantable Cardiac Devices Market Overview
    2 Global Implantable Cardiac Devices Market Competitions by Manufacturers
    3 Global Implantable Cardiac Devices Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Implantable Cardiac Devices Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Implantable Cardiac Devices Production, Revenue (Value), Price Trend by Type
    6 Global Implantable Cardiac Devices Market Analysis by Application
    7 Global Implantable Cardiac Devices Manufacturers Profiles/Analysis
    8 Implantable Cardiac Devices Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Implantable Cardiac Devices Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 29, 2018 ) Global Implantable Cardiac Pacemaker Ma Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Implantable Cardiac Pacemaker Ma. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Implantable Cardiac Pacemaker Ma market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Implantable Cardiac Pacemaker Ma Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-implantable-cardiac-pacemaker-market-research-report-2018

    With this Implantable Cardiac Pacemaker Ma Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, Livanova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1355666

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Implantable Cardiac Pacemaker Ma Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1355666

    List of Chapters:
    1 Implantable Cardiac Pacemaker Ma Market Overview
    2 Global Implantable Cardiac Pacemaker Ma Market Competitions by Manufacturers
    3 Global Implantable Cardiac Pacemaker Ma Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Implantable Cardiac Pacemaker Ma Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Implantable Cardiac Pacemaker Ma Production, Revenue (Value), Price Trend by Type
    6 Global Implantable Cardiac Pacemaker Ma Market Analysis by Application
    7 Global Implantable Cardiac Pacemaker Ma Manufacturers Profiles/Analysis
    8 Implantable Cardiac Pacemaker Ma Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Implantable Cardiac Pacemaker Ma Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 29, 2018 ) Global Patient Monitoring Systems Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Patient Monitoring Systems. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Patient Monitoring Systems market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Patient Monitoring Systems Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-patient-monitoring-systems-market-research-report-2018

    With this Patient Monitoring Systems Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Ge Healthcare, Medtronic, Philips Healthcare, Lifewatch, Nihon Kohden, Omron Corporation, Honeywell International, Bard Medical, Welch Allyn, Infinium Medical, Delta, Syncro Medical and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1355667

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Patient Monitoring Systems Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1355667

    List of Chapters:
    1 Patient Monitoring Systems Market Overview
    2 Global Patient Monitoring Systems Market Competitions by Manufacturers
    3 Global Patient Monitoring Systems Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Patient Monitoring Systems Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Patient Monitoring Systems Production, Revenue (Value), Price Trend by Type
    6 Global Patient Monitoring Systems Market Analysis by Application
    7 Global Patient Monitoring Systems Manufacturers Profiles/Analysis
    8 Patient Monitoring Systems Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Patient Monitoring Systems Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 29, 2018 ) Global Premature Infant Incubator Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Premature Infant Incubator. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Premature Infant Incubator market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Premature Infant Incubator Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-premature-infant-incubator-market-research-report-2018

    With this Premature Infant Incubator Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Ge Healthcare, Draeger, Atom Medical, Natus Medical, David, Fanem, Shvabe, Dison, Mediprema, Jw Medical, Phoenix, Cobams, Weyer, Beijing Julongsanyou, Medicor, Ginevri, Olidef, V-Care Medical, Pt. Fyrom, Ertunc Özcan and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1355668

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Premature Infant Incubator Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1355668

    List of Chapters:
    1 Premature Infant Incubator Market Overview
    2 Global Premature Infant Incubator Market Competitions by Manufacturers
    3 Global Premature Infant Incubator Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Premature Infant Incubator Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Premature Infant Incubator Production, Revenue (Value), Price Trend by Type
    6 Global Premature Infant Incubator Market Analysis by Application
    7 Global Premature Infant Incubator Manufacturers Profiles/Analysis
    8 Premature Infant Incubator Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Premature Infant Incubator Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 29, 2018 ) An iliac artery stent is small wire mesh which is used to treat the patient suffering from cardiovascular disorder. Iliac artery stent has its crucial application in holding open the iliac artery for the patent suffering from arteriosclerosis. Generally, iliac arteries are of two types, internal and external iliac arteries. The major role of the iliac artery is to carry blood from the heart to pelvis and legs. Atherosclerosis is a severe disease which affects the blood vessels such as iliac artery.

    Atherosclerosis is generally caused due to deposition of fat and cholesterol within the blood vessel which lead to thickening of blood vessel wall. The thickened blood vessel wall become narrow which is responsible for the blockage of blood flow from the iliac artery. To remove this blockage from the iliac artery, a thin guide wire is inserted in the upper thigh of the patient through the small incision. This guide wire is attached with iliac artery stents and this process is generally visualized using the x-ray and special dye. This guide wire is inserted into the femoral artery and it is guided until it reaches the iliac artery. A balloon catheter is placed on the tip of the guide wire and it is inflated inside the narrow artery. After deflation of balloon, guide wire is removed from the artery. As the balloon is deflated but the stent remains in the narrow place to remove the blockage of the blood vessel.

    The rise in incidences of cardiovascular disease throughout the globe is the primary factor driving the growth of iliac artery stents market. Rapid technological advancement and wide acceptance of stenting procedure among the patent also fuelling the growth of iliac artery stents market over the forecast period. Moreover, increasing demand for minimally invasive surgery and rising geriatric population is also responsible for the robust growth of iliac artery stents market. On other hand, various alternative treatment options are available in the market for the treatment of cardiovascular disease which will deter the growth of iliac artery stents market to some extent. Also, the number of product recall and risk of failure during the surgery will lead to the sluggish growth of this market. Additionally, stringent regulation by FDA for the approval of any stents will also hamper the growth of iliac artery stents market over the forecast period.

    Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1106

    The global iliac artery stents market is classified on the basis of product type, wound type, end user and region.

    Based on product type, iliac artery stents market is segmented into following:

    Balloon Expandable Stent
    Self-Expandable Stents

    Based on end user, iliac artery stents market is segmented into following:

    Hospitals
    Ambulatory Surgical Centers
    Cardiac Catheterization Centers

    The global iliac artery stents market is expected to show significant growth over the forecast period owing to increased aging population and rising adoption of minimally invasive surgery. According to WHO, more than 200 million people are suffering from pulmonary artery disorder throughout the globe. WHO, also estimated that 12-20% of the global geriatric population is suffering from pulmonary artery disorder. By product type, balloon expandable stent will dominate the iliac artery stent market share by revenue owing to the high preference of surgeon to use this type of stent during the minimally invasive surgery. Among all end user, cardiac catheterization center will grow with the faster CAGR due to increasing number of minimally invasive surgery in this end user facility in last decade.

    Request for Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1106

    On the basis of geography, iliac artery stents market is classified in seven key region viz. North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East and Africa. North America is expected to dominate the global iliac Artery Stents market due high prevalence of cardiovascular disorders. After North America Iliac Artery Stents market is followed by Europe and APEC. The increasing adoption of minimally invasive surgery is responsible for robust growth iliac artery stents market in the European region. APEC region will also show noteworthy growth for iliac artery stents market owing to rising prevalence of geriatric population in India and Japan. MEA and Latin America is expected to be a less lucrative market for iliac artery stents due lack of awareness among the patient about the minimally invasive surgery.

    Some of the key players found across the value chain of iliac artery stents market are Boston Scientific Corporation, Cordis Corporation, Abbott Vascular, Inc, W.L. Gore & Associates, Becton, Dickinson and Company, Medtronic plc, Cook Medical Inc. and others.

    Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1106



    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

older | 1 | .... | 1126 | 1127 | (Page 1128) | 1129 | 1130 | .... | 1146 | newer